Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity
ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients
ALK is a novel dependence receptor - Potential implications in development and cancer
ALK translocation is associated with ALK immunoreactivity and extensive signet-ring morphology in primary lung adenocarcinoma
ALK and MYCN: When Two Oncogenes Are Better than One
ALK pERKs Up MYCN in Neuroblastoma
ALK FISH and IHC You Cannot Have One without the Other
ALK Status Testing in Non-Small Cell Lung Carcinoma Correlation Between Ultrasensitive IHC and FISH
ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors
ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma
ALK Gene Copy Number Gain and Immunohistochemical Expression Status Using Three Antibodies in Neuroblastoma
ALK gene alterations in cancer: biological aspects and therapeutic implications
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes
ALK alterations and inhibition in lung cancer
ALK Expression is a Rare Finding in Mycosis Fungoides
ALK Testing in Lung Adenocarcinoma Technical Aspects to Improve FISH Evaluation in Daily Practice
ALK Rearrangement and Overexpression in an Unusual Cutaneous Epithelioid Tumor With a Peculiar Whorled "Perineurioma-like" Growth Pattern: Epithelioid Fibrous Histiocytoma
ALK and IGF-1R as independent targets in crizotinib resistant lung cancer
ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen
ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma
ALK immunohistochemistry for ALK gene rearrangement screening in non-small cell lung cancer: a systematic review and meta-analysis
ALK and ROS1 non-small-cell lung cancer: two molecular subgroups sensitive to targeted therapy
ALK germline mutations in patients with neuroblastorna: a rare and weakly penetrant syndrome
ALK Translocation in Non-small Cell Lung Cancer with Adenocarcinoma and Squamous Cell Carcinoma Markers
ALK Rearrangement in Sickle Cell Trait-Associated Renal Medullary Carcinoma
ALK and ROS1 rearrangement in NSCLC: rapidly evolving standards
ALK fusion genes in children with atypical myeloproliferative leukemia
ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosis
ALK inhibitors in non-small cell lung cancer: the latest evidence and developments
ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues
ALK alteration is a frequent event in aggressive breast cancers
ALK evaluation in the world of multiplex testing: Network Genomic Medicine (NGM): the Cologne model for implementing personalised oncology
ALK expression plays different roles in anaplastic large-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK plus patients in a Chinese population
ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy
ALK Protein Expression Is Related to Neuroblastoma Aggressiveness But Is Not Independent Prognostic Factor
ALK and ROS1 Double-Rearranged Lung Squamous Cell Carcinoma Responding to Crizotinib Treatment: A Case Report
ALK Rearrangements Are Infrequent in Cellular Blue Nevus and Deep Penetrating Nevus
ALK inhibitors, resistance development, clinical trials
ALK and ROS1 rearrangements, coexistence and treatment in epidermal growth factor receptor-wild type lung adenocarcinoma: a multicenter study of 732 cases
ALK positive lung cancer identification and targeted drugs evaluation using microscopic hyperspectral imaging technique
ALK(R1275Q) perturbs extracellular matrix, enhances cell invasion and leads to the development of neuroblastoma in cooperation with MYCN
ALK(+)ALCLs induce cutaneous, HMGB-1-dependent IL-8/CXCL8 production by keratinocytes through NF-kappa B activation
ALK(+) small cell variant of anaplastic large cell lymphoma with leukemic presentation
ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: A comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features
ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare
ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours
ALK-positive extramedullary plasmacytoma with expression of the CLTC-ALK fusion transcript
ALK-negative anaplastic large cell lymphoma with extensive peripheral blood and bone marrow involvements manifested as "leukemic phase"
ALK-Rearranged Lung Cancer in Chinese: A Comprehensive Assessment of Clinicopathology, IHC, FISH and RT-PCR
ALK-重排性肺癌的综合组织学分析(英)
ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
ALK-negative anaplastic large cell lymphoma primarily involving the bronchus: a case report and literature review
ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study
ALK-Dependent Control of Hypoxia-Inducible Factors Mediates Tumor Growth and Metastasis
ALK-Positive Non-Small Cell Lung Cancer Mechanisms of Resistance and Emerging Treatment Options
ALK-positive diffuse large B-cell lymphoma of the duodenum: A case report and review of the literature
ALK-positive cancer: still a growing entity
ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma Patients
ALK-positive anaplastic large cell lymphoma presenting as intradural spinal mass: First reported case and review of literature
ALK-Positive Inflammatory Myofibroblastic Tumor of the Abdomen With Widespread Microscopic Multifocality
ALK-positive large B-cell lymphoma presenting with jejunal intussusception
ALK-rearranged non-small cell lung cancer: how to optimize treatment with crizotinib in routine practice?
ALK-positive anaplastic large cell lymphoma with prominent bone involvement in a 13-year-old boy
ALK-negative anaplastic large-cell lymphoma
ALK-rearranged renal cell carcinomas in children
ALK-Positive Inflammatory Myofibroblastic Tumor of the Nipple During Pregnancy-An Unusual Presentation of a Rare Disease
ALK-negative anaplastic large cell lymphoma is sensitive to bortezomib through Noxa upregulation and release of Bax from Bcl-2
ALK-rearranged squamous cell lung cancer: a case report
ALK-positive anaplastic large cell lymphoma presenting with hemophagocytic lymphohistiocytosis
ALK-mediated post-transcriptional regulation: focus on RNA-binding proteins
ALK-rearranged non-small cell lung cancers: how best to optimize the safety of crizotinib in clinical practice?
ALK-5 Inhibition: A Molecular Interpretation of the Main Physicochemical Properties Related to Bioactive Ligands
ALK-positive Primary Systemic Anaplastic Large Cell Lymphoma with Extensive Cutaneous Manifestation
ALK-Positive Anaplastic Large Cell Lymphoma in a Patient With Chronic Lymphocytic Leukemia
ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy
ALK-negative anaplastic large cell lymphoma with CNS involvement needs more than just brentuximab vedotin
ALK-rearranged adenocarcinoma with extensive mucin production can mimic mucinous adenocarcinoma: clinicopathological analysis and comprehensive histological comparison with KRAS-mutated mucinous adenocarcinoma
ALK-Activating Homologous Mutations in LTK Induce Cellular Transformation
ALK-immunoreactive neoplasms
ALK-1-Negative Anaplastic Large Cell Lymphoma Associated With Breast Implants: A New Clinical Entity
ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects - a review
ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified